CLBS - Caladrius Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Caladrius Biosciences's activity chart (see below) currently has 4 price targets and 7 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by from HC WAINWRIGHT on 06-Jun-2022.

Best performing analysts who are covering CLBS - Caladrius Biosciences:

Joseph Pantginis Raghuram Selvaraju Jason Kolbert Keay Nakae Kumaraguru Raja

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Nov-2018

4 years 3 months 29 days ago
(06-Jun-2022)

0/2 (0%)

$13.85 (297.85%)

Buy Since 20-Nov-2018

$18.5

4 years 6 months 12 days ago
(23-Mar-2022)

0/2 (0%)

$14.07 (317.61%)

Buy Since 22-May-2020

$7

$6.57 (1527.91%)

$7

5 years 7 months 2 days ago
(03-Mar-2021)

0/2 (0%)

$5.1 (268.42%)

Buy Since 15-Mar-2019

$6

$5.57 (1295.35%)

7 years 6 months 20 days ago
(15-Mar-2019)

0/1 (0%)

$2.08 (53.06%)

Show more analysts

Please expand the browser size to see the chart

Which analyst most recently updated their price target on CLBS (Caladrius Biosciences)?

Which analyst has the most public recommendations on CLBS (Caladrius Biosciences)?

has 0 price targets and 0 ratings on CLBS

Which analyst is the currently most bullish on CLBS (Caladrius Biosciences)?

Raghuram Selvaraju with the highest potential upside of $18.07

Which analyst is the currently most reserved on CLBS (Caladrius Biosciences)?

Joseph Pantginis with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?